Senna Tablet
NDC 83324-004
Product Information
Senna (sennosides) is a OTC MONOGRAPH DRUG-approved product labeled by Quality Choice (chain Drug Marketing Association). Sennosides are used to treat constipation. It is supplied as a brown tablet for oral administration. This product entry covers the primary NDC 83324-004 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
P23
Code Structure Chart
Product Details
What is NDC 83324-004?
What are the uses of this product?
What are Active Ingredients of this product?
- SENNOSIDES 8.6 mg/1 - Medications derived from SENNA EXTRACT that are used to treat CONSTIPATION.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SENNOSIDES (UNII: 3FYP5M0IJX)
- SENNOSIDES (UNII: 3FYP5M0IJX) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- TALC (UNII: 7SEV7J4R1U)
- TRIACETIN (UNII: XHX3C3X673)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 312935 - sennosides 8.6 MG Oral Tablet
- RxCUI: 312935 - sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 312935 - sennosides A and B 8.6 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.